Canada markets closed

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4850-0.0250 (-4.90%)
At close: 3:57PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 572.83M
Enterprise Value 364.78M
Trailing P/E N/A
Forward P/E 1-4.04
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.09
Price/Book (mrq)1.12
Enterprise Value/Revenue 38.09
Enterprise Value/EBITDA 7-2.08

Trading Information

Stock Price History

Beta (5Y Monthly) 2.10
52-Week Change 3-1.92%
S&P500 52-Week Change 349.17%
52 Week High 30.9000
52 Week Low 30.3250
50-Day Moving Average 30.5774
200-Day Moving Average 30.4626

Share Statistics

Avg Vol (3 month) 3872.77k
Avg Vol (10 day) 3378.59k
Shares Outstanding 5150.17M
Implied Shares Outstanding 6N/A
Float 133.54M
% Held by Insiders 111.22%
% Held by Institutions 12.18%
Shares Short (Apr. 14, 2021) 4228.63k
Short Ratio (Apr. 14, 2021) 40.41
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.15%
Shares Short (prior month Mar. 14, 2021) 41.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 23, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3May 23, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-388.74%

Management Effectiveness

Return on Assets (ttm)-25.05%
Return on Equity (ttm)-44.71%

Income Statement

Revenue (ttm)8.01M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-30.50%
Gross Profit (ttm)2.44M
EBITDA -31.09M
Net Income Avi to Common (ttm)-29.9M
Diluted EPS (ttm)-0.2630
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.62M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)2.82M
Total Debt/Equity (mrq)5.51
Current Ratio (mrq)3.49
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-27.29M
Levered Free Cash Flow (ttm)-21.53M